§ Service

HIPAA-Compliant Medical Marketing

HIPAA-compliant medical marketing.

Abstract

Patient testimonials, identifiable before-and-after imagery, and identifiable case-study material require written authorization under 45 CFR 164.508. The five required elements of the authorization are the workflow. We build the consent template against the federal standard plus the state medical board overlay, and we route every testimonial through that workflow before it reaches a service page.

Book a diagnostic →

This service surface is one of seven inside the Medical SEO practice at Praxis. The consent-workflow design integrates with the schema layer, the directory work, and the editorial-content surface. If you need to route the consent-workflow question into a wider intake with the medical seo expert team, the homepage carries the full service map and the scoping path.

How the consent workflow ships

Four consent surfaces. Each one cited by section number.

The consent surfaces for patient testimonials, practice-announcement communications, case-study content, and before-and-after imagery have different federal and state-overlay rules. We map them per-surface so the practice can ship outcomes-based content without compliance fragility.

The 45 CFR 164.508 written-authorization workflow.

Patient testimonials, identifiable before/after imagery, and identifiable case-study material require written authorization. The authorization names what gets disclosed, who receives it, the purpose, an expiration date, and the patient's revocation rights. The five elements are the workflow. We build the consent form against the federal standard plus the state medical board overlay where it adds specificity (Florida testimonial-typicality, California, Texas, New York each layer additional rules), and we route every testimonial through that workflow before it reaches a service page.

The 45 CFR 164.501 marketing-exception path.

Practice-announcement communications about a new physician arrival or a new service line are exempt from per-recipient marketing authorization. Treatment-communication exceptions (prescription refill reminders, care-coordination referrals) similarly. The exemptions hold as long as the practice is not being paid by a third party to send the communication. We map the patient-outreach calendar against the exemption so the routine announcements do not carry compliance overhead, and we flag third-party-remuneration triggers when they appear.

The case-study consent path.

De-identified case presentations with explicit consent forms are the most commonly exploited path for surfacing patient outcomes without per-testimonial authorization. The consent scope is distinct from text-testimonial consent. We design the case-study consent template for the practice, calibrate the de-identification standard against the safe-harbor pattern (per the 18 HIPAA Safe Harbor identifiers under 45 CFR 164.514), and review case-study drafts before they ship.

Before-and-after-imagery consent scoped separately.

Plastic surgery and dermatology buyers care about this specifically. The 45 CFR 164.508 specificity requirement means before-and-after-imagery consent is scoped separately from any text testimonial. different identifiability surface, different patient-reasonable-expectations test, different revocation surface. The authorization template captures imagery-specific disclosure language, the duration of use, the surfaces the imagery will appear on, and the patient's right to revoke at any time.

Side by side

The consent workflow versus the default, on the four surfaces where it matters most.

Practice with Praxis workflow

Federal + state-overlay calibrated

Practice without consent workflow

Compliance-fragile by default

Patient testimonial on service page

Routes through the 45 CFR 164.508 five-element authorization template before publication. State medical board overlay applied where it adds specificity.

Patient quote shipped without consent record. Patient retains revocation rights the practice cannot evidence having explained.

Before-and-after imagery

Imagery-specific consent template captured separately from text testimonial. Surfaces of use enumerated. Revocation surface designed.

Imagery published under generic photo release. 164.508 specificity standard unmet for identifiable clinical imagery.

Practice-announcement email about new physician

Mapped against the 164.501 own-products-and-services exception. Per-recipient authorization not required. Third-party-remuneration trigger monitored.

Either over-protected (consent collected unnecessarily, slowing announcements) or under-protected (third-party-paid promotions sent without authorization).

Case study with patient outcomes

De-identified per the 18 Safe Harbor identifiers under 164.514. Explicit consent collected for the case-study format separately from any testimonial form.

Outcomes published with quasi-identifiers (rare combination, specific date, specific location) that re-identify the patient under expert determination.

Multi-state telehealth disclosure

AMA Code Opinion 1.2.12 telehealth continuity surfaced in the consent. Cross-state licensure footprint aligned with geographic targeting.

Cross-state advertising surface unaligned with physician state-license footprint. Digital-footprint signals unlicensed practice in non-licensed states.

Practice with Praxis workflow

Federal + state-overlay calibrated

Patient testimonial on service page: Routes through the 45 CFR 164.508 five-element authorization template before publication. State medical board overlay applied where it adds specificity.
Before-and-after imagery: Imagery-specific consent template captured separately from text testimonial. Surfaces of use enumerated. Revocation surface designed.
Practice-announcement email about new physician: Mapped against the 164.501 own-products-and-services exception. Per-recipient authorization not required. Third-party-remuneration trigger monitored.
Case study with patient outcomes: De-identified per the 18 Safe Harbor identifiers under 164.514. Explicit consent collected for the case-study format separately from any testimonial form.
Multi-state telehealth disclosure: AMA Code Opinion 1.2.12 telehealth continuity surfaced in the consent. Cross-state licensure footprint aligned with geographic targeting.

Practice without consent workflow

Compliance-fragile by default

Patient testimonial on service page: Patient quote shipped without consent record. Patient retains revocation rights the practice cannot evidence having explained.
Before-and-after imagery: Imagery published under generic photo release. 164.508 specificity standard unmet for identifiable clinical imagery.
Practice-announcement email about new physician: Either over-protected (consent collected unnecessarily, slowing announcements) or under-protected (third-party-paid promotions sent without authorization).
Case study with patient outcomes: Outcomes published with quasi-identifiers (rare combination, specific date, specific location) that re-identify the patient under expert determination.
Multi-state telehealth disclosure: Cross-state advertising surface unaligned with physician state-license footprint. Digital-footprint signals unlicensed practice in non-licensed states.

Updated 2026-05-28

How we engage

Diagnostic, then monthly retainer. Four phases, each scoped against cited deliverables.

Weeks 0-2

Diagnostic

We read your Search Console data, your traffic data, your current Schema.org markup, your physician author bylines, your testimonial pages, and your directory-profile completeness. The diagnostic comes back with the load-bearing pages, the dead weight, the YMYL-fragile content, and the entity-graph gaps. For multi-location groups, we add a GBP audit per practicing location.
Weeks 2-6

Schema and author layer

We build the MedicalBusiness and Physician schema layer with sameAs chains to NPI registry, ABMS verification, and state medical board profiles. Author bylines surface ABMS specialty and active state license alignment. CPT-aligned service pages where the procedure mix supports it. The schema layer reflects what each page actually is, MedicalCondition / MedicalProcedure types reserved for the editorial layer.
Weeks 4-8

Reviews System alignment

Editorial content rebuilt against the Reviews System 2023+ medical-content framework. Practicing-physician reviewer signals on first-party content. PubMed-cited primary literature replacing health-magazine summaries. Topic-to-specialty alignment in every author byline (a general practitioner does not author complex oncological articles). Patient testimonial workflow routed through the 45 CFR 164.508 consent path before any testimonial lands on a service page.
Monthly

Ongoing retainer

Monthly cadence on the rest of the site, plus content cadence for the queries the diagnostic surfaced. Quarterly review against your traffic data and Search Console movement. Re-audit of the entity-graph reconciliation when physician rosters change. Re-audit of the consent workflow when state medical board advertising rules change.

Common questions

Questions practice administrators ask before booking a diagnostic.

01.

Is Praxis a HIPAA covered entity or business associate?

Praxis is a marketing services agency. We are not a covered entity under the HIPAA Privacy Rule. Our engagement model is designed so that we do not handle protected health information directly. The consent workflow we ship runs at the client side: the covered entity collects authorization under 45 CFR 164.508 before any identifiable testimonial or imagery reaches our hands or the site. If your specific engagement scope requires us to receive PHI, we sign a Business Associate Agreement before any handoff.

02.

Can we just collect a signed photo release like other businesses do?

A generic photo release does not satisfy 45 CFR 164.508 for identifiable clinical imagery. The authorization has to name what gets disclosed, who receives it, the purpose, an expiration date, and the patient's revocation rights. A photo release that the practice uses for office headshots is not the same instrument as a consent for publishing identifiable before-and-after-procedure imagery to your service page. The federal specificity standard applies to the medical-marketing surface specifically.

03.

How does Praxis handle the 'own products and services' exception?

45 CFR 164.501 exempts practice-announcement communications and treatment-communication contexts from per-recipient marketing authorization, as long as the practice is not being paid by a third party to send the communication. We map your patient-outreach calendar against the exemption so routine announcements (new physician arrival, new service-line launch, prescription refill reminders, care-coordination referrals) do not carry compliance overhead. The moment a third party pays for the communication, the exemption breaks; we flag that trigger when it appears in the workflow.

04.

What about state medical board rules on top of HIPAA?

HIPAA sets the federal floor. State medical board advertising rules layer additional specificity. Florida requires testimonial-typicality representation, a retained-consent-period, and disclaimers. California, Texas, and New York each layer additional rules. The multi-state telehealth practice has to clear the strictest market's bar. We do not state a strict-state rule as if it were federal; the per-state overlay is documented inside the consent template the practice uses.

05.

How does this connect to the rest of the SEO work?

The consent-workflow design feeds the testimonial contract on the site: before a testimonial renders, the rendering layer verifies the consent_authorization_id field is present. The case-study path drives a separate content stream that does not collide with the testimonial schema. The before-and-after-imagery workflow informs the schema choice on procedure pages (commercial pages keep MedicalBusiness + availableService; clinical types stay on editorial content). The whole testimonial-and-outcome surface is designed so the SEO architecture and the regulatory workflow do not contradict each other.

06.

Do you author medical content for the practice?

We author SEO architecture, schema, editorial structure, and the regulatory framing around clinical content. The medical-substance content itself is authored or reviewed by credentialed practicing physicians at your practice. Praxis as an entity does not provide medical advice or treatment, and the author bylines on your site reflect that. The disclaimer in your footer states it explicitly.

Stop watching your competitors rank

If you've shipped patient outcomes without a consent record, we'll show you the workflow.

The diagnostic comes back inside two weeks with the testimonial surfaces audited against 45 CFR 164.508, the case-study path mapped against 45 CFR 164.501, and the state medical board overlay applied where the practice operates.

Book a diagnostic → Email us